PDCD1 and classic Hodgkin lymphoma: In conclusion, this study for the first time reveals a correlation between pretreatment peripheral PNR and prognosis of anti‐PD‐1‐based therapy in patients with relapsed/refractory cHL and advanced solid tumor.